In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

GUIDANT ACS Rx MULTI-LINK HAS 70% U.S. STENT MARKET DOLLAR VOLUME; EVEREST MEDICAL ATTRIBUTES 10% OF FOURTH-QUARTER VOLUME TO GUIDANT VASOVIEW BUSINESS

This article was originally published in The Gray Sheet

Executive Summary

Sales of Guidant's ACS Rx Multi-Link stent, launched on Oct. 2, topped $200 mil. in the fourth quarter of 1997, the company reported Feb. 3. According to Guidant President and CEO Ronald Dollens, who spoke the same day at a Piper Jaffray investor conference in New York City, the product now accounts for roughly 70% of the dollar volume and 60% of the unit volume of a U.S. stent market that is rapidly approaching an estimated $1 bil.
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT009536

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel